FKTN rs1057517160: Understanding This Genetic Variant
The rs1057517160 variant is located within the FKTN gene, which is essential for muscle and brain development. This variant is studied in the context of muscular dystrophies and related congenital disorders.
What each genotype means
Heterozygous carrier status
You carry one copy of the insertion variant and one copy of the reference sequence. While this variant is cataloged in clinical databases, its specific functional impact on the FKTN gene remains under investigation. You should discuss these results with a genetic counselor or healthcare provider to understand if this finding has any relevance to your personal or family health history.
This genotype is observed in clinical databases, though it is less common than the homozygous reference state.
Homozygous variant profile
You carry two copies of this insertion variant. The clinical significance of being homozygous for this specific insertion is not fully established in current medical literature. Because the FKTN gene is associated with various forms of muscular dystrophy, you should consult with a medical professional to determine if this finding requires further clinical evaluation or context.
This genotype is documented in clinical databases but is considered less common than the reference genotype.
What is rs1057517160?
The rs1057517160 variant is a specific genetic marker located on chromosome 9 within the FKTN gene. In genetics, an rsID (reference SNP cluster ID) acts as a unique identifier for a specific location in the human genome where a variation may occur. This particular variant involves a sequence change that researchers track to understand its potential impact on biological function. Because the human genome is vast, these identifiers allow scientists to aggregate data across global studies, helping to determine if a specific change at this location correlates with health outcomes. While many variants in the genome are benign and represent normal human diversity, others are investigated for their role in altering protein production or function. The study of rs1057517160 is part of a broader effort to map the genetic landscape of the FKTN gene and its influence on human health.
The Role of the FKTN Gene
The FKTN gene provides the instructions for the body to produce an enzyme called fukutin. This enzyme plays a critical role in the modification of a protein known as alpha-dystroglycan. This modification process, called glycosylation, is essential for the proper structure and function of muscle fibers and the migration of neurons during early brain development. When the FKTN gene contains variants that disrupt the production or function of fukutin, the resulting alpha-dystroglycan may not be properly stabilized. This can lead to a group of conditions known as dystroglycanopathies, which include various forms of muscular dystrophy. These conditions are characterized by muscle weakness, developmental delays, and in some cases, structural brain abnormalities. Understanding the function of the FKTN gene is fundamental to grasping why certain genetic variations in this region are associated with significant health challenges.
Research and Evidence Strength
Research into the FKTN gene has established a clear link between certain variants and congenital muscular dystrophies, such as Fukuyama-type congenital muscular dystrophy. The evidence for the pathogenicity of specific variants in this gene is often derived from clinical observations of individuals presenting with muscle weakness, hypotonia, and brain malformations. For rs1057517160, the evidence strength is categorized as moderate, meaning that while it is documented in clinical databases, ongoing research is required to fully characterize its specific clinical impact across different populations. It is important to note that the presence of a variant does not automatically imply a diagnosis. Genetic associations are statistical in nature, and the clinical expression of FKTN-related conditions is complex, often requiring the presence of variants on both copies of the gene in an autosomal recessive inheritance pattern. Clinicians and genetic counselors use this information to guide diagnostic testing and family planning.
Population Frequency
The frequency of genetic variants can vary significantly depending on ancestral background. Some variants in the FKTN gene are notably more common in specific populations, such as the Japanese population, where certain mutations are a known cause of Fukuyama congenital muscular dystrophy. For rs1057517160, the variant is noted as being common in ClinVar, which serves as a repository for clinically significant variants. However, 'common' in a clinical database does not necessarily mean the variant is common in the general population; it often reflects that the variant has been frequently submitted for analysis due to its potential clinical relevance. Researchers use large-scale databases like gnomAD to determine the true prevalence of such variants across diverse global ancestries. Understanding these frequency patterns is essential for interpreting genetic test results accurately and avoiding biases in clinical risk assessment.
What You Can Do With This Information
Genetic information regarding variants like rs1057517160 is best utilized in consultation with a qualified healthcare professional, such as a medical geneticist or a genetic counselor. If you have received a report mentioning this variant, it is important to remember that it does not constitute a medical diagnosis. Genetic testing results should always be interpreted within the context of your personal and family medical history, as well as physical examinations. You cannot use this information to self-diagnose or predict health outcomes in isolation. If you are concerned about muscular dystrophy or related symptoms, a clinician can order appropriate diagnostic tests and provide guidance based on the most current clinical guidelines. Avoid making health decisions based solely on raw genetic data, as the interpretation of these variants is a specialized field that requires professional expertise to ensure accuracy and clinical utility.
How common is this variant?
The variant is noted as common in ClinVar, though its prevalence in the general population varies by ancestry and should be verified through large-scale databases like gnomAD.
Frequently asked questions
Is rs1057517160 a diagnosis for muscular dystrophy?
No, the presence of this variant is not a diagnosis. Genetic variants are only one piece of a complex clinical puzzle that includes physical symptoms, family history, and other diagnostic tests.
What should I do if my genetic report shows this variant?
You should schedule an appointment with a genetic counselor or a medical geneticist. They can help you understand what this result means for your specific health context and whether further testing is necessary.
Are all FKTN variants harmful?
No, many genetic variants are benign and do not affect health. Only specific variants that disrupt the function of the fukutin enzyme are associated with muscular dystrophy.
How is FKTN-related muscular dystrophy inherited?
These conditions typically follow an autosomal recessive inheritance pattern. This means an individual usually needs to inherit two copies of a pathogenic variant—one from each parent—to develop the condition.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057517160?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29